EODData

FRA, 1KA: GH RESEARCH PLC DL-025

03 Sep 2025
LAST:

11.60

CHANGE:
 0.30
OPEN:
11.60
HIGH:
11.60
ASK:
0.00
VOLUME:
9
CHG(%):
2.65
PREV:
11.30
LOW:
11.60
BID:
0.00
 

CHART

RECENT END OF DAY PRICES

DateOpenHighLowCloseVolume
03 Sep 2511.6011.6011.6011.609
02 Sep 2511.1011.3011.1011.309
01 Sep 2511.1011.9011.1011.909
29 Aug 2511.5011.5011.3011.30102
28 Aug 2511.3011.3011.3011.30102
27 Aug 2511.1011.1011.1011.10102
26 Aug 2510.9010.9010.9010.90102
25 Aug 2510.8010.8010.8010.80102
22 Aug 2510.8010.8010.8010.80102
21 Aug 2510.6010.6010.6010.60102

COMPANY PROFILE

Name:GH RESEARCH PLC DL-025
About:GH Research PLC, together with its subsidiary, a clinical-stage biopharmaceutical company, engages in developing treatments for depression in the United States. Its lead product candidate is GH001, an inhalable mebufotenin product candidate, which is in phase 2b clinical trial for treating patients with treatment-resistant depression; and in phase 2a clinical trial for treating bipolar II disorder and a current major depressive episode, as well as female patients with postpartum depression. The company also develops GH002, an intravenous mebufotenin product candidate, which is in phase 1 clinical pharmacology trial in healthy volunteers focusing on psychiatric and neurological disorders. The company was founded in 2018 and is based in Dublin, Ireland.
Sector:Healthcare
Industry:Biotechnology
Address:Joshua Dawson House, Dublin, Ireland, D02 RY95
Website:https://www.ghres.com
ISIN:IE000GID8VI0

SYMBOL HISTORY

   Add to Watchlist

DOWNLOAD DATA

Download stock quote history quickly and easily in a variety of formats to suit your needs.

TECHNICAL INDICATORS

MA5:11.48
MA10:11.16
MA20:10.69
MA50:11.70
MA100:10.57
MA200:9.97
STO9:72.73
STO14:80.00
RSI14:74.07
WPR14:-20.00
MTM14:1.10
ROC14:0.10
ATR:0.24
Week High:11.90
Week Low:11.10
Month High:11.90
Month Low:9.75
Year High:19.42
Year Low:5.64